-
-
Small Molecule Drug Platforms
-
Chiral Catalysis Technology
-
Continuous Flow Technology
-
Fluorine Chemistry
-
Enzyme Catalysis
-
Photocatalysis
-
Solid-State Research
显示更多 -
-
Drug Product (DP) Platforms
-
Sustained and Controlled Release
-
Solubility Enhancement
-
Topical Formulation
-
Liquid Formulation
-
Softgels
-
Oral Fast Dissolving Technology
显示更多 -
-
Peptide Platforms
显示更多 -
Research Team
-
GMP Peptide Manufacturing: Ensuring the Quality of Peptide Drugs with International Compliance Standards
Release time:
2025-12-22
1. Strict Adherence to Global GMP Regulatory Requirements
GMP peptide manufacturing is the key foundation for the successful entry of peptide drugs into the global market. In Europe, the US, and other major pharmaceutical markets, the production of peptide APIs must strictly comply with international GMP regulations, with clear requirements for facilities, processes, personnel, and quality systems.

2. Structured Quality Management System (QMS)
In the peptide manufacturing environment, a structured quality management system (QMS) with end-to-end traceability must be established, encompassing raw material inspection, in-process controls, and release testing.
Through standardized operating procedures (SOPs) and continuous deviation management, the risk of batch variations is effectively reduced, ensuring the stability and reproducibility of product quality.
3. Supporting Both Clinical and Commercialization Needs
A mature GMP peptide manufacturing platform can support not only small-scale production for early-stage clinical projects but also seamlessly transition to large-scale supply during the commercialization phase. Through modular production design and flexible scheduling mechanisms, it can meet the diverse needs of clients at different stages of development.
In the context of increasingly stringent global regulatory environments, partners with stable GMP peptide manufacturing capabilities are becoming a crucial support force for international pharmaceutical companies in advancing peptide drug development.
Other News
2026-11-10
Winter Process Chemistry Conference
2026-11-03
2026-11-03
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Established Business Services(API)
Tel: 86-576-88881561
E-mail: bd@jiuzhoupharma.com